During cancer development, cells often experience a variety of stresses, which can lead them to adopt a form of cell aging termed “senescence.” This study dissects how the presence of senescent cells in breast cancer influences disease progression, and tests whether drugs that specifically kill cells in this state can improve disease therapy.